Trial Profile
An Open-Label Randomized Multiple-Dose Study to Evaluate Levofloxacin Steady-State Pharmacokinetics and Safety in Subjects With Varying Degrees of Renal Function.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2010
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 08 Apr 2010 New trial record